MedTrace Logo

Bone Density in Voluntary Apheresis Blood Donors

NCT02655055 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2022-03-09

No results posted yet for this study

Summary

A longitudinal, randomized, controlled, single-center Phase IV clinical trial will be performed to assess changes in bone mineral density (BMD) among voluntary apheresis blood donors. The primary outcome measure will be clinically significant decline in BMD at the lumbar spine assessed by dual-energy x-ray absorptiometry (DXA).

Conditions

  • Bone Density

Interventions

PROCEDURE

high frequency voluntary apheresis blood donation

Sponsors & Collaborators

  • Marquette University

    collaborator OTHER

  • Medical College of Wisconsin

    collaborator OTHER

  • University of Wisconsin, Milwaukee

    collaborator OTHER

  • Versiti

    lead OTHER

Principal Investigators

  • Paula E Papanek, PhD · Marquette University

  • Walter Bialkowski, MS · Versiti

  • Robert D Blank, MD, PhD · Medical College of Wisconsin

  • Jerome L Gottschall, MD · Versiti

  • Cheng Zheng, PhD · University of Wisconsin, Milwaukee

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-01-31
Completion
2018-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02655055 on ClinicalTrials.gov